COVID-19: Blood cancer patients gain antibodies from vaccine booster - study
Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.
An undated transmission electron micrograph of SARS-CoV-2 virus particles, also known as novel coronavirus, the virus which causes COVID-19, isolated from a patient.(photo credit: NIAID INTEGRATED RESEARCH FACILITY (IRF)/HANDOUT VIA REUTERS)ByAARON REICHUpdated:
